| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/17/2008 | WO2007074405A3 Dsrna as insect control agent |
| 04/17/2008 | WO2007072224A3 Increasing levels of nicotinic alkaloids |
| 04/17/2008 | WO2007016276A3 Marker-free plant transformation |
| 04/17/2008 | WO2004067709A8 Identification of essential genes of aspergillus fumigatus and methods of use |
| 04/17/2008 | WO1999001471A9 Nik proteins, nucleic acids and methods |
| 04/17/2008 | US20080092254 Transgenic Plants with Reduced Level of Saturated Fatty Acid and Methods for Making Them |
| 04/17/2008 | US20080092253 Soybean Cultivar 4211676 |
| 04/17/2008 | US20080092252 Enhanced Expression |
| 04/17/2008 | US20080092251 Expression vector comprising nucleotide sequences coding oxidoreductase for enhancing oil production in transgenic crops |
| 04/17/2008 | US20080092249 Method of nuclear transfer |
| 04/17/2008 | US20080091004 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080091003 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080091002 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 04/17/2008 | US20080091001 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080091000 Stress-inducible plant promoters |
| 04/17/2008 | US20080090997 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 04/17/2008 | US20080090994 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080090959 Epoxide polymer surfaces |
| 04/17/2008 | US20080090918 Macroporous gel; cooling aqueous solution of gel forming polymer and solvent at a temperature which freezes solvent |
| 04/17/2008 | US20080090778 Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| 04/17/2008 | US20080090777 Long lasting drug formulations |
| 04/17/2008 | US20080090776 Obtained from lung cancer patients; cDNA and genomic DNA of a novel fusion polynucleotide of an EML4 gene fused with an ALK gene as kinase (EML4-ALK fusion polynucleotide variant 1); for screening a therapeutic agent for cancer, treating cancer |
| 04/17/2008 | US20080090764 Partially dePEGylated lysine/N-terminal positional PEG isomers of a recombinant G-CSF polypeptide, such recombinant G-CSF polypeptide containing the substitutions K16R, K34R, K40R, T105K and S159K relative to wild-type human G-CSF; increasing the level of neutrophils in a patient |
| 04/17/2008 | US20080090763 Novel gene encoding a dna repair enzyme and methods of use thereof |
| 04/17/2008 | US20080090762 Epithelum-derived T-cell factor |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090747 modified subtilisin, comprises at least one substitution in the sequence set forth in SEQ ID NO:2, in the position selected from Gly118, Ser128, Pro129, Ser130, and Ser166; use in dishwashing formulation, highly effective in removing proteinaceous soils from dishware |
| 04/17/2008 | US20080090745 Host cells with inactivated protease genes; point mutations; cultures; laundry detergents |
| 04/17/2008 | US20080090294 Methods of Protecting Plants from Pathogenic Fungi and Nematodes |
| 04/17/2008 | US20080090293 Methods of Protecting Plants from Pathogenic Fungi and Nematodes |
| 04/17/2008 | US20080090291 Synthetic nucleic acid molecule compositions and methods of preparation |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/17/2008 | US20080090280 Polypeptides Of Botryospaeria Rhodina |
| 04/17/2008 | US20080090279 Expression vector comprising nucleotide sequences coding lactase/hydrolase for use in production of low lactose milk in mammals |
| 04/17/2008 | US20080090277 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 04/17/2008 | US20080090272 Metabolic engineering of amino acid production |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080090257 Compositions and methods for inhibiting or inducing adipogenesis |
| 04/17/2008 | US20080090249 Ube2g2 Binding Domain in The Ubiquitin Ligase Gp78 And Methods Of Use Thereof |
| 04/17/2008 | US20080090241 Using primer amplification to identify lepidopteran insect resistant cotton; biological pest control |
| 04/17/2008 | US20080090226 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080090224 Nucleic acid detection |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089910 Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
| 04/17/2008 | US20080089904 Clostridium toxin, and process for the preparation of immunogenic composition |
| 04/17/2008 | US20080089903 Cd4+t-lymphocyte-specific hepatitis c virus epitopes |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089888 Nucleotide sequences coding cancer/testis antigen for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089886 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089879 Phytases and methods of making and using them |
| 04/17/2008 | US20080089873 Method for Regenerating Hair Follicles by Suppressing a Gene with Hair Follicle Formation-Inhibiting Ability or by Activating a Gene with Hair Follicle Formation-Inducing Ability |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | US20080089864 Viral sequences for targeted replication in tumor cells |
| 04/17/2008 | US20080089863 Non-Integrative And Non-Replicative Lentivirus , Preparation And Uses Thereof |
| 04/17/2008 | US20080089862 Serine protease inhibitor for prevention and treatment of cell proliferative, liver and inflammatory disorders |
| 04/17/2008 | US20080089837 monoclonal antibodies directed to the antigen Platelet derived growth factor-alpha |
| 04/17/2008 | CA2791144A1 Protease screening methods and proteases identified thereby |
| 04/17/2008 | CA2703466A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | CA2683109A1 Combination therapy |
| 04/17/2008 | CA2673533A1 Enhancement of hybridoma fusion efficiencies through cell synchronization |
| 04/17/2008 | CA2668818A1 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
| 04/17/2008 | CA2666511A1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof |
| 04/17/2008 | CA2666249A1 Agent for preventing/treating cancer |
| 04/17/2008 | CA2666191A1 Rna antagonist compounds for the modulation of pcsk9 |
| 04/17/2008 | CA2666185A1 Influenza targets |
| 04/17/2008 | CA2665948A1 Reliable detection of vancomycin-intermediate staphylococcus aureus |
| 04/17/2008 | CA2665766A1 Process for generation of protein and uses thereof |
| 04/17/2008 | CA2665739A1 Improvement of the kernel productivity of plants through the modulation of glutamine synthetase activity |
| 04/17/2008 | CA2665691A1 Agent for therapy and/or improvement of disseminated intravascular coagulation |
| 04/17/2008 | CA2665595A1 Glucoamylase variants with altered properties |
| 04/17/2008 | CA2665521A1 Cellulase-free enzyme compositions and host cells for producing the same |
| 04/17/2008 | CA2665068A1 Methods for treating cancer with mva |
| 04/17/2008 | CA2664517A1 Ph sensitive liposome composition |
| 04/17/2008 | CA2663959A1 Plants with increased yield |
| 04/17/2008 | CA2663811A1 Maize microrna sequences |
| 04/17/2008 | CA2660861A1 Method for increasing pathogen resistance in transgenic plants |
| 04/16/2008 | EP1912130A1 Pathway display method, information processing device, and pathway display program |
| 04/16/2008 | EP1912069A2 Method to screen ligands using eukaryotic cell display |
| 04/16/2008 | EP1911847A1 Improvement of the kernel productivity of maize through the modulation of glutamine synthetase activity |
| 04/16/2008 | EP1911846A2 Genes which encode proteins for glucose-6-phosphate-dehydrogenase |
| 04/16/2008 | EP1911845A2 Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with diseases caused by necrotrophic fungal pathogens |
| 04/16/2008 | EP1911844A1 Methods and kit for isolating nucleic acids |
| 04/16/2008 | EP1911843A1 Genetically modified microorganism and process for production of macrolide compound using the microorganism |
| 04/16/2008 | EP1911842A1 EXPRESSION VECTOR HAVING PROMOTER SEQUENCE OF Vasa HOMOLOGUE GENE DERIVED FROM MAMMAL AND USE THEREOF |
| 04/16/2008 | EP1911841A1 Methods for production of proteins |
| 04/16/2008 | EP1911840A1 tRNA SYNTHESIS METHOD, NUCLEIC ACID, AMINOACYL tRNA SYNTHESIS METHOD, AND PROCESS FOR PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN |
| 04/16/2008 | EP1911839A1 Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911767A2 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 04/16/2008 | EP1911459A1 Lymphangiogenesis promoter |
| 04/16/2008 | EP1910570A2 Gene galnt6 as breast cancer marker and small interfering rnas directed against gene galnt6 |
| 04/16/2008 | EP1910550A2 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 04/16/2008 | EP1910548A1 Method of delivering nucleic acid molecules into embryonic stem cells using baculoviral vectors |